$2.39
-0.08 (-3.24%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,428.5% upside
Low Target
$23.38
Average Target
$36.53
High Target
$47.42
Current Price
$2.39
Current
$2.39
$2.39
Target
$36.53
$36.53
$23.38
$36.53 avg
$47.42
Scenario Analysis
Bear Case
$23.38
878.2%
Low target
Base Case
$36.53
+1,428.5%
Avg target
Bull Case
$47.42
+1,884.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$13.93
-82.8% from high
52-Week Low
$1.87
+27.8% from low
Target vs 52W High
$36.53
+162.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.5% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +139.2% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.5% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.1% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.9% |